Floatz logo

FLUOROURACILUM

Invasive Breast Cancer

Dr. Tabassum WadasadawalaSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Invasive Breast Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BB
Inno-206
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BB
TAMOXIFEN
University of California, San Francisco
Phase 2BB
Atezolizumab
Fondazione Michelangelo
Phase 3B
Mometasone
Memorial Sloan Kettering Cancer Center
Phase 3B

View all 26 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →